CEACAM5 and neoplasm: We conducted this external validation study to prospectively assess and validate the tumor markers CYFRA 21–1, CEA, and SCC in cytological fluid obtained from NAB samples to determine if they improved the performance of NAB for diagnosing NSCLC compared to serum tumor markers.